Mechanical ventilators optimized for pediatric use decrease work of breathing and oxygen consumption during pressure-support ventilation

Neurally Adjusted Ventilatory Assist Is Associated with Greater Initial Extubation Success in Postoperative Congenital Heart Disease Patients when Compared to Conventional Mechanical Ventilation

Extubation failure is associated with considerable morbidity and mortality in postoperative patients with congenital heart disease (CHD). The study purpose was to investigate initial extubation success utilizing neurally adjusted ventilatory assist (NAVA) compared with pressure-regulated volume controlled, synchronized intermittent mandatory ventilation with pressure support (SIMV-PRVC + PS) for ventilatory weaning in patients who required prolonged mechanical ventilation (MV). Also, total days on MV, inotropes, sedation, analgesia, and pediatric intensive care unit (PICU) length of stay (LOS) between both groups were compared. This was a non-randomized pilot study utilizing historical controls (SIMV-PRVC + PS; n  = 40) compared with a prospective study population (NAVA; n  = 35) in a Level I PICU and was implemented to help future trial designs. All patients ( n  = 75) required prolonged MV ≥96 hours due to their complex postoperative course. Ventilator weaning initiation and management was standardized between both groups. Ninety-seven percent of the NAVA group was successfully extubated on the initial attempt, while 80% were in the SIMV-PRVC + PS group ( p  = 0.0317). Patients placed on NAVA were eight times more likely to have successful initial extubation (odds ratio [OR]: 8.50, 95% confidence interval [CI]: 1.01, 71.82). The NAVA group demonstrated a shorter median duration on MV (9.0 vs. 11.0 days, p  = 0.032), PICU LOS (9.0 vs. 13.5 days, p  < 0.0001), and shorter median duration of days on dopamine (8.0 vs. 11.0 days, p  = 0.0022), milrinone (9.0 vs. 12.0 days, p  = 0.0002), midazolam (8.0 vs. 12.0 days, p  < 0.0001), and fentanyl (9.0 vs. 12.5 days, p  < 0.0001) compared with the SIMV-PRVC + PS group. NAVA compared with SIMV-PRVC + PS was associated with a greater initial extubation success rate. NAVA should be considered as a mechanical ventilator weaning strategy in postoperative congenital heart disease (CHD) patients and warrants further investigation.

Comparison of total resistive work of breathing in two generations of ventilators in an animal model

Spontaneous breathing through an endotracheal tube and ventilator circuit is associated with an increased work of breathing (WOB). Recently, pediatric ventilators have introduced improved features to optimize patient-ventilator interactions. We performed an experiment utilizing an animal model to compare total resistive WOB of two widely used ventilators, the Siemens Servo Ventilator 300 (SV300) with patient-optimized features, such as flow-triggering and rapid response time, and the Siemens 900C (S900C) without those features. A total of 120 experiments of 10 minutes duration each were performed in 6 anesthetized, intubated lambs. In each experiment, the animal was randomized to either pressure support ventilation (PSV) of 5 cm H2O, or continuous positive airway pressure (CPAP) with 0 cmH2O end expiratory pressure (ZEEP) while supported by the SV300 or the S900C. Each animal was used as its own control. WOB was measured with a Bicore monitoring device as WOB of the animal (WOBp), WOB of the ventilator (WOBv), and the pressure time product (PTP) for each breath during the experiment. Oxygen consumption (Vo2) of the animal was measured using breath-by-breath gas analysis with a customized metabolic monitoring system. A Wilcoxon signed rank sum test was used for analysis. All comparisons between the ventilators for both CPAP and PSV showed a statistically significant difference (p < 0.001). WOBp was reduced by 47% during pressure support ventilation (PSV) and by 47% during CPAP when the SV300 was used compared to the S900C. We conclude that WOB is significantly lower in animals ventilated with the SV300 than with the S900C ventilator, and we speculate that ventilators with the features of the SV300 may offer advantages in ventilating pediatric patients.